Literature DB >> 6756908

Correlation between intestinal immune response to colonization factor antigen/I and acquired resistance to enterotoxigenic Escherichia coli diarrhea in an adult rabbit model.

D G Evans, F J de la Cabada, D J Evans.   

Abstract

Immunoprotection against diarrhea caused by colonization factor antigen/I (CFA/I)-positive, human-associated, enterotoxigenic Escherichia coli was investigated using the adult rabbit intestinal temporary ligation technique. An oral dose of 1 X 10(8) viable cells of enterotoxigenic Escherichia coli strain H-10407 (078:H11:CFA/I) produced diarrhea in all animals challenged. Rabbits allowed to survive this challenge dose were re-challenged approximately six weeks later with the result that four of seven (57%) did not develop diarrhea. Peroral immunization of rabbits with purified CFA/I elicited protection against challenge with strain H-10407; this protection was dose-related and CFA/I-specific. Immunoprotection did not correlate with a systemic antibody response. CFA/I produced a relatively poor immune response in terms of the number of IgM- and IgG-producing cells in the lamina propria of the animals but did elicit a vigorous increase in the number of intestinal IgA- and anti-CFA/I-producing cells. There was a highly significant inverse relationship between the number of IgA- and anti-CFA/I-producing cells in the lamina propria of the rabbits and the diarrhea response to the challenge strain H-10407 (correlation coefficients of -0.616 and -0.678 respectively). It is concluded that anti-CFA/I antibody, probably of the IgA class, is the major immune response to orally administered CFA/I and that this response is highly immunoprotective.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6756908     DOI: 10.1007/bf02019620

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  14 in total

1.  Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin.

Authors:  J Ngan; L S Kind
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

2.  Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen.

Authors:  D G Evans; T K Satterwhite; D J Evans; H L DuPont
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

3.  Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans.

Authors:  D G Evans; R P Silver; D J Evans; D G Chase; S L Gorbach
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

4.  Purification and characterization of the CFA/I antigen of enterotoxigenic Escherichia coli.

Authors:  D G Evans; D J Evans; S Clegg; J A Pauley
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

5.  Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children.

Authors:  F Orskov; I Orskov; D J Evans; R B Sack; D A Sack; T Wadström
Journal:  Med Microbiol Immunol       Date:  1976-06-01       Impact factor: 3.402

6.  Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration.

Authors:  J A Mattingly; B H Waksman
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

7.  New surface-associated heat-labile colonization factor antigen (CFA/II) produced by enterotoxigenic Escherichia coli of serogroups O6 and O8.

Authors:  D G Evans; D J Evans
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

8.  Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea.

Authors:  W M Spira; R B Sack; J L Froehlich
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

9.  Enzyme-linked immunosorbent assay for quantitating the humoral immune response to the colonization factor antigen of enterotoxigenic Escherichia coli.

Authors:  S Clegg; D G Evans; D J Evans
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

10.  Cellular kinetics of the intestinal immune response to cholera toxoid in rats.

Authors:  N F Pierce; J L Gowans
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Monoclonal antibodies against different epitopes on colonization factor antigen I of enterotoxin-producing Escherichia coli.

Authors:  Y Lopez-Vidal; P Klemm; A M Svennerholm
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

3.  Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans.

Authors:  M M Levine; P Ristaino; G Marley; C Smyth; S Knutton; E Boedeker; R Black; C Young; M L Clements; C Cheney
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

Review 4.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

5.  Intestinal immune responses in patients infected with enterotoxigenic Escherichia coli and in vaccinees.

Authors:  C Wennerås; F Qadri; P K Bardhan; R B Sack; A M Svennerholm
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  Rabbit model of rotavirus infection.

Authors:  M E Conner; M K Estes; D Y Graham
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

7.  Mucosal antitoxin response in volunteers to immunization with a synthetic peptide of Escherichia coli heat-stable enterotoxin.

Authors:  F A Klipstein; R F Engert; R A Houghten
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.